Medicinal Chemistry--13th RSC-SCI Symposium.
Herrick
Victoria
V
Thomson Scientific, Middlesex House, London, UK. victoria.herrick@thomson.com
D000818:Animals; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors; D043884:Receptor, Cannabinoid, CB1 / Q000819:agonists; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D020845:Selective Estrogen Receptor Modulators / Q000138:chemical synthesis / Q000494:pharmacology; D013329:Structure-Activity Relationship; D000099052:CRF Receptor, Type 1
D004791:Enzyme Inhibitors; D043884:Receptor, Cannabinoid, CB1; D018019:Receptors, Corticotropin-Releasing Hormone; D020845:Selective Estrogen Receptor Modulators; D000099052:CRF Receptor, Type 1; D020928:Mitogen-Activated Protein Kinases